Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 ShMerck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 ShMerck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh

Merck & Co., Inc. Shs Cert Deposito Arg Repr 1/5 Sh

No trades
See on Supercharts

Key facts today


Merck & Co. is raising $5 billion in bonds to fund its $10 billion acquisition of Verona Pharma, with Bank of America leading the financing through various notes and bonds.
Merck & Co. plans to invest $895 million to expand its animal health site in Kansas, part of a $9 billion U.S. investment by 2028, while managing potential tariff impacts.
Biocytogen Pharmaceuticals has entered into an agreement with Merck & Co. to advance the development of antibody-conjugated lipid-based delivery solutions.
Analyze the impactAnalyze the impact
Market capitalization
‪213.51 B‬USD
1.15USD
‪15.20 B‬USD
‪56.82 B‬USD
Beta (1Y)
0.15

About Merck & Company, Inc.


CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
ISIN
ARDEUT110277
FIGI
BBG000FT0R36
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Check out other big names from the same industry as MRKD.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
MRK3675698
Merck & Co., Inc. 5.85% 30-JUN-2039
Yield to maturity
Maturity date
Jun 30, 2039
MRK3671638
Schering-Plough Corporation 6.55% 15-SEP-2037
Yield to maturity
Maturity date
Sep 15, 2037
MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050
Yield to maturity
Maturity date
Jun 24, 2050
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061
Yield to maturity
Maturity date
Dec 10, 2061
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063
Yield to maturity
Maturity date
May 17, 2063
MRK3900816
Merck & Co., Inc. 3.6% 15-SEP-2042
Yield to maturity
Maturity date
Sep 15, 2042
MRK.GJ
Merck & Co., Inc. FRN 06-FEB-2041
Yield to maturity
Maturity date
Feb 6, 2041
MRK5584925
Merck & Co., Inc. 4.9% 17-MAY-2044
Yield to maturity
Maturity date
May 17, 2044
MRK4806277
Merck & Co., Inc. 3.4% 07-MAR-2029
Yield to maturity
Maturity date
Mar 7, 2029
MRK5584755
Merck & Co., Inc. 5.0% 17-MAY-2053
Yield to maturity
Maturity date
May 17, 2053
MRK5584924
Merck & Co., Inc. 4.5% 17-MAY-2033
Yield to maturity
Maturity date
May 17, 2033

See all MRKD bonds